BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6412970)

  • 1. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA; Jones RJ
    Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
    Roe EA; Jones RJ
    Rev Infect Dis; 1983; 5 Suppl 5():S922-30. PubMed ID: 6419315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
    Lieberman MM; Walker HL; Ayala E; Chapa I
    J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
    Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
    Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines against Pseudomonas aeruginosa infection: 2. Clinico-immunological investigations.
    Krokhina MA; Grishina IA; Panova YuM ; Terekhova RP; Severtsova MK; Yedvabnaya LS; Vaide M; Varro R; Rusanov VM; Kolker II
    Vaccine; 1985 Sep; 3(3):316-24. PubMed ID: 3933202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL; Purdue GF
    J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection.
    Montie TC; Drake D; Sellin H; Slater O; Edmonds S
    Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heptavalent pseudomonas vaccination in seriously burned children.
    O'Neill JA; Nance FC; Fisher MW
    J Pediatr Surg; 1971 Oct; 6(5):547-53. PubMed ID: 5001632
    [No Abstract]   [Full Text] [Related]  

  • 16. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ; Lowbury EJ
    Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by vaccination against Pseudomonas infection after thermal injury.
    Markley K; Smallman E
    J Bacteriol; 1968 Oct; 96(4):867-74. PubMed ID: 4971892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas vaccine and hyperimmune plasma for burned patients.
    Feller I; Pierson C
    Arch Surg; 1968 Aug; 97(2):225-9. PubMed ID: 5657428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.